Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
The effect of Helicobacter pylori in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) is unclear. We investigated the effects of H pylori eradication in patients with current or previous peptic ulceration, dyspepsia, or both who continued to use NSAIDs. 285 patients were randomly as...
Gespeichert in:
| Veröffentlicht in: | The Lancet (British edition) 1998-09, Vol.352 (9133), p.1016-1021 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1021 |
|---|---|
| container_issue | 9133 |
| container_start_page | 1016 |
| container_title | The Lancet (British edition) |
| container_volume | 352 |
| creator | Hawkey, CJ Tulassay, Z Szczepanski, L van Rensburg, CJ Filipowicz-Sosnowska, A Lanas, A Wason, CM Peacock, RA Gillon, KRW |
| description | The effect of
Helicobacter pylori in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) is unclear. We investigated the effects of
H pylori eradication in patients with current or previous peptic ulceration, dyspepsia, or both who continued to use NSAIDs.
285 patients were randomly assigned omeprazole 20 mg, amoxycillin 1000 mg, and clarithromycin 500 mg, twice daily (n=142,
H pylori eradication treatment), or omeprazole with placebo antibiotics (n=143, controls) for 1 week. All patients received omeprazole 20 mg once daily for 3 weeks until endoscopy, and, if the ulcer was not healed, 40 mg once daily until repeat endoscopy at 8 weeks. Ulcer-free patients with mild dyspepsia continued NSAIDs but not antiulcer treatment. We investigated ulcers with endoscopy at 1, 3, and 6 months and with carbon-13-labelled urea breath test at 3 months.
The estimated probability of being ulcer-free at 6 months was 0.56 (95% CI 0.47–0.65) on eradication treatment and 0·53 (0·44–0·62) on on control treatment (p=0·80). Time to treatment failure did not differ between groups for ulcers or dyspepsia alone, per-protocol analysis, or final
H pylori status. 66% (58–74) of the eradication group compared with 14% (8–20) of the control group had a final negative
H pylori result (p |
| doi_str_mv | 10.1016/S0140-6736(98)04206-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_199028739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673698042068</els_id><sourcerecordid>34783791</sourcerecordid><originalsourceid>FETCH-LOGICAL-c358t-2079ac5a02987b19a554ffc0344d0575e7f0777ce9b5841b858d4292187620ea3</originalsourceid><addsrcrecordid>eNqFkM1KJDEUhcOgMO3PIwjB1cyi9KYqqSSzEfGvhUaHUcFdSCcpiVQnPUla6BfwuY22uHV1z4VzzuV-CB0QOCJA-uM7IBSannf9Lyl-A22hb8QPNCGU04ZR_riFJl-Wn2gn52cAoD2wCXr9p4ONC5-dxSaGkuI4VlmS1yOOA5660Zs416a4hJfrMSaPXdLWG118DNgHvKzKhZJxXUMMTa7W6G3N61B848Mw6sVCl5jW2KbVU_6Dpxezv_jm7vT6PONcVna9h7YHPWa3_zl30cPlxf3ZtJndXl2fnc4a0zFRmha41IZpaKXgcyI1Y3QYDHSUWmCcOT4A59w4OWeCkrlgwtJWtkTwvgWnu110uOldpvh_5XJRz3GVQj2piJTQCt7JamIbk0kx5-QGtUx-odNaEVDvxNUHcfWOU0mhPogrUXMnm5yrH7x4l1Q2lYxx1idnirLRf9PwBtKZiVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199028739</pqid></control><display><type>article</type><title>Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study</title><source>Elsevier ScienceDirect Journals Complete</source><source>EBSCOhost Business Source Complete</source><creator>Hawkey, CJ ; Tulassay, Z ; Szczepanski, L ; van Rensburg, CJ ; Filipowicz-Sosnowska, A ; Lanas, A ; Wason, CM ; Peacock, RA ; Gillon, KRW</creator><creatorcontrib>Hawkey, CJ ; Tulassay, Z ; Szczepanski, L ; van Rensburg, CJ ; Filipowicz-Sosnowska, A ; Lanas, A ; Wason, CM ; Peacock, RA ; Gillon, KRW</creatorcontrib><description>The effect of
Helicobacter pylori in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) is unclear. We investigated the effects of
H pylori eradication in patients with current or previous peptic ulceration, dyspepsia, or both who continued to use NSAIDs.
285 patients were randomly assigned omeprazole 20 mg, amoxycillin 1000 mg, and clarithromycin 500 mg, twice daily (n=142,
H pylori eradication treatment), or omeprazole with placebo antibiotics (n=143, controls) for 1 week. All patients received omeprazole 20 mg once daily for 3 weeks until endoscopy, and, if the ulcer was not healed, 40 mg once daily until repeat endoscopy at 8 weeks. Ulcer-free patients with mild dyspepsia continued NSAIDs but not antiulcer treatment. We investigated ulcers with endoscopy at 1, 3, and 6 months and with carbon-13-labelled urea breath test at 3 months.
The estimated probability of being ulcer-free at 6 months was 0.56 (95% CI 0.47–0.65) on eradication treatment and 0·53 (0·44–0·62) on on control treatment (p=0·80). Time to treatment failure did not differ between groups for ulcers or dyspepsia alone, per-protocol analysis, or final
H pylori status. 66% (58–74) of the eradication group compared with 14% (8–20) of the control group had a final negative
H pylori result (p<0·001). Fewer baseline gastric ulcers healed among eradication-treatment patients than among controls (72
vs 100% at 8 weeks, p=0·006).
H pylori eradication in long-term users of NSAIDs with past or current peptic ulcer or troublesome dyspepsia led to impaired healing of gastric ulcers and did not affect the rate of peptic ulcers or dyspepsia over 6 months.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(98)04206-8</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Anti-inflammatory agents ; Antibiotics ; Bacteria ; Carbon 13 ; Drug therapy ; Infections ; Nonsteroidal anti-inflammatory drugs ; Ulcers ; Urea</subject><ispartof>The Lancet (British edition), 1998-09, Vol.352 (9133), p.1016-1021</ispartof><rights>1998 Elsevier Ltd</rights><rights>Copyright Lancet Ltd. Sep 26, 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c358t-2079ac5a02987b19a554ffc0344d0575e7f0777ce9b5841b858d4292187620ea3</citedby><cites>FETCH-LOGICAL-c358t-2079ac5a02987b19a554ffc0344d0575e7f0777ce9b5841b858d4292187620ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673698042068$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Hawkey, CJ</creatorcontrib><creatorcontrib>Tulassay, Z</creatorcontrib><creatorcontrib>Szczepanski, L</creatorcontrib><creatorcontrib>van Rensburg, CJ</creatorcontrib><creatorcontrib>Filipowicz-Sosnowska, A</creatorcontrib><creatorcontrib>Lanas, A</creatorcontrib><creatorcontrib>Wason, CM</creatorcontrib><creatorcontrib>Peacock, RA</creatorcontrib><creatorcontrib>Gillon, KRW</creatorcontrib><title>Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study</title><title>The Lancet (British edition)</title><description>The effect of
Helicobacter pylori in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) is unclear. We investigated the effects of
H pylori eradication in patients with current or previous peptic ulceration, dyspepsia, or both who continued to use NSAIDs.
285 patients were randomly assigned omeprazole 20 mg, amoxycillin 1000 mg, and clarithromycin 500 mg, twice daily (n=142,
H pylori eradication treatment), or omeprazole with placebo antibiotics (n=143, controls) for 1 week. All patients received omeprazole 20 mg once daily for 3 weeks until endoscopy, and, if the ulcer was not healed, 40 mg once daily until repeat endoscopy at 8 weeks. Ulcer-free patients with mild dyspepsia continued NSAIDs but not antiulcer treatment. We investigated ulcers with endoscopy at 1, 3, and 6 months and with carbon-13-labelled urea breath test at 3 months.
The estimated probability of being ulcer-free at 6 months was 0.56 (95% CI 0.47–0.65) on eradication treatment and 0·53 (0·44–0·62) on on control treatment (p=0·80). Time to treatment failure did not differ between groups for ulcers or dyspepsia alone, per-protocol analysis, or final
H pylori status. 66% (58–74) of the eradication group compared with 14% (8–20) of the control group had a final negative
H pylori result (p<0·001). Fewer baseline gastric ulcers healed among eradication-treatment patients than among controls (72
vs 100% at 8 weeks, p=0·006).
H pylori eradication in long-term users of NSAIDs with past or current peptic ulcer or troublesome dyspepsia led to impaired healing of gastric ulcers and did not affect the rate of peptic ulcers or dyspepsia over 6 months.</description><subject>Anti-inflammatory agents</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Carbon 13</subject><subject>Drug therapy</subject><subject>Infections</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Ulcers</subject><subject>Urea</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkM1KJDEUhcOgMO3PIwjB1cyi9KYqqSSzEfGvhUaHUcFdSCcpiVQnPUla6BfwuY22uHV1z4VzzuV-CB0QOCJA-uM7IBSannf9Lyl-A22hb8QPNCGU04ZR_riFJl-Wn2gn52cAoD2wCXr9p4ONC5-dxSaGkuI4VlmS1yOOA5660Zs416a4hJfrMSaPXdLWG118DNgHvKzKhZJxXUMMTa7W6G3N61B848Mw6sVCl5jW2KbVU_6Dpxezv_jm7vT6PONcVna9h7YHPWa3_zl30cPlxf3ZtJndXl2fnc4a0zFRmha41IZpaKXgcyI1Y3QYDHSUWmCcOT4A59w4OWeCkrlgwtJWtkTwvgWnu110uOldpvh_5XJRz3GVQj2piJTQCt7JamIbk0kx5-QGtUx-odNaEVDvxNUHcfWOU0mhPogrUXMnm5yrH7x4l1Q2lYxx1idnirLRf9PwBtKZiVA</recordid><startdate>19980926</startdate><enddate>19980926</enddate><creator>Hawkey, CJ</creator><creator>Tulassay, Z</creator><creator>Szczepanski, L</creator><creator>van Rensburg, CJ</creator><creator>Filipowicz-Sosnowska, A</creator><creator>Lanas, A</creator><creator>Wason, CM</creator><creator>Peacock, RA</creator><creator>Gillon, KRW</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>19980926</creationdate><title>Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study</title><author>Hawkey, CJ ; Tulassay, Z ; Szczepanski, L ; van Rensburg, CJ ; Filipowicz-Sosnowska, A ; Lanas, A ; Wason, CM ; Peacock, RA ; Gillon, KRW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c358t-2079ac5a02987b19a554ffc0344d0575e7f0777ce9b5841b858d4292187620ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Anti-inflammatory agents</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Carbon 13</topic><topic>Drug therapy</topic><topic>Infections</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Ulcers</topic><topic>Urea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hawkey, CJ</creatorcontrib><creatorcontrib>Tulassay, Z</creatorcontrib><creatorcontrib>Szczepanski, L</creatorcontrib><creatorcontrib>van Rensburg, CJ</creatorcontrib><creatorcontrib>Filipowicz-Sosnowska, A</creatorcontrib><creatorcontrib>Lanas, A</creatorcontrib><creatorcontrib>Wason, CM</creatorcontrib><creatorcontrib>Peacock, RA</creatorcontrib><creatorcontrib>Gillon, KRW</creatorcontrib><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hawkey, CJ</au><au>Tulassay, Z</au><au>Szczepanski, L</au><au>van Rensburg, CJ</au><au>Filipowicz-Sosnowska, A</au><au>Lanas, A</au><au>Wason, CM</au><au>Peacock, RA</au><au>Gillon, KRW</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study</atitle><jtitle>The Lancet (British edition)</jtitle><date>1998-09-26</date><risdate>1998</risdate><volume>352</volume><issue>9133</issue><spage>1016</spage><epage>1021</epage><pages>1016-1021</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>The effect of
Helicobacter pylori in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) is unclear. We investigated the effects of
H pylori eradication in patients with current or previous peptic ulceration, dyspepsia, or both who continued to use NSAIDs.
285 patients were randomly assigned omeprazole 20 mg, amoxycillin 1000 mg, and clarithromycin 500 mg, twice daily (n=142,
H pylori eradication treatment), or omeprazole with placebo antibiotics (n=143, controls) for 1 week. All patients received omeprazole 20 mg once daily for 3 weeks until endoscopy, and, if the ulcer was not healed, 40 mg once daily until repeat endoscopy at 8 weeks. Ulcer-free patients with mild dyspepsia continued NSAIDs but not antiulcer treatment. We investigated ulcers with endoscopy at 1, 3, and 6 months and with carbon-13-labelled urea breath test at 3 months.
The estimated probability of being ulcer-free at 6 months was 0.56 (95% CI 0.47–0.65) on eradication treatment and 0·53 (0·44–0·62) on on control treatment (p=0·80). Time to treatment failure did not differ between groups for ulcers or dyspepsia alone, per-protocol analysis, or final
H pylori status. 66% (58–74) of the eradication group compared with 14% (8–20) of the control group had a final negative
H pylori result (p<0·001). Fewer baseline gastric ulcers healed among eradication-treatment patients than among controls (72
vs 100% at 8 weeks, p=0·006).
H pylori eradication in long-term users of NSAIDs with past or current peptic ulcer or troublesome dyspepsia led to impaired healing of gastric ulcers and did not affect the rate of peptic ulcers or dyspepsia over 6 months.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><doi>10.1016/S0140-6736(98)04206-8</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0140-6736 |
| ispartof | The Lancet (British edition), 1998-09, Vol.352 (9133), p.1016-1021 |
| issn | 0140-6736 1474-547X |
| language | eng |
| recordid | cdi_proquest_journals_199028739 |
| source | Elsevier ScienceDirect Journals Complete; EBSCOhost Business Source Complete |
| subjects | Anti-inflammatory agents Antibiotics Bacteria Carbon 13 Drug therapy Infections Nonsteroidal anti-inflammatory drugs Ulcers Urea |
| title | Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T01%3A37%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Randomised%20controlled%20trial%20of%20Helicobacter%20pylori%20eradication%20in%20patients%20on%20non-steroidal%20anti-inflammatory%20drugs:%20HELP%20NSAIDs%20study&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Hawkey,%20CJ&rft.date=1998-09-26&rft.volume=352&rft.issue=9133&rft.spage=1016&rft.epage=1021&rft.pages=1016-1021&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(98)04206-8&rft_dat=%3Cproquest_cross%3E34783791%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199028739&rft_id=info:pmid/&rft_els_id=S0140673698042068&rfr_iscdi=true |